BlackRock Inc. - PHIO PHARMACEUTICALS CORP ownership

PHIO PHARMACEUTICALS CORP's ticker is PHIOXXXX and the CUSIP is 71880W204. A total of 14 filers reported holding PHIO PHARMACEUTICALS CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of PHIO PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2019$01,1150.0%0.00%
Q3 2019$01,1150.0%0.00%
Q2 2019$01,1150.0%0.00%
Q1 2019$01,1150.0%0.00%
Q4 2018$01,1150.00%
Other shareholders
PHIO PHARMACEUTICALS CORP shareholders Q4 2018
NameSharesValueWeighting ↓
CVI Holdings, LLC 155,135$51,0000.11%
SABBY MANAGEMENT, LLC 1,575,157$520,0000.11%
EDMOND DE ROTHSCHILD HOLDING S.A. 10,790$4,0000.00%
Advisor Group, Inc. 19$00.00%
BANK OF AMERICA CORP /DE/ 65$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SG Americas Securities, LLC 163,730$54,0000.00%
MORGAN STANLEY 5,718$2,0000.00%
BlackRock Inc. 1,115$00.00%
Citadel Advisors 19,886$7,0000.00%
View complete list of PHIO PHARMACEUTICALS CORP shareholders